Century Therapeutics, Inc. revenue for the last year amounted to 2.23 M USD, the most of which — 2.23 M USD — came from its highest performing source at the moment, Allogeneic Cell Therapies, the year earlier bringing 5.20 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Century Therapeutics, Inc. 2.23 M USD, and the year before that — 5.20 M USD.